Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial.
Rosenzwajg M, Gherasim A, Dietsch F, Beck M, Domis N, Lorenzon R, Chantran Y, Bellier B, Vicaut E, Soria A, De Blay F, Klatzmann D.
Rosenzwajg M, et al. Among authors: beck m.
J Allergy Clin Immunol. 2024 Nov 10:S0091-6749(24)01181-3. doi: 10.1016/j.jaci.2024.10.033. Online ahead of print.
J Allergy Clin Immunol. 2024.
PMID: 39532189